share_log

Inozyme Pharma | SC 13G: Statement of acquisition of beneficial ownership by individuals-Eventide Asset Management, LLC(5.15%),Finny Kuruvilla, M.D. Ph. D.(5.15%), etc.

SEC announcement ·  Feb 14 11:57
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more